Market Synopsis of Benign positional vertigo Market:
The Benign Positional Vertigo Market is growing at the CAGR of ~4.10% during the forecast period 2022-2030.
Benign Positional Vertigo or Benign paroxysmal positional vertigo (BPPV) is disorder related to inner ear. Vertigo is feeling of spinning or everything is spinning around. Increasing number of cases of benign positional disorder is the major factor for the market growth. New treatments and product development are also key driving forces for the benign positional vertigo market. Increasing awareness of the disorder and treatment options are leading the market growth. Medicine, devices and accessories manufacturers are developing new products for the market. Moreover, increasing funding for R&D of advanced product development are major drivers for the market.
Study objectives of Benign Positional Vertigo Market:
FIGURE 1 BENIGN POSITIONAL VERTIGO MARKET SHARE, BY TREATMEN Sources: American Hearing Research Foundation, National Center for Biotechnology Information, U.S. Directorate of Industries, Annual report, White paper, Company Presentation Directorate of Industries, Annual report, White paper, Company Presentation
Key Players for Benign positional vertigo Market:
Some of the key players in this market are: Ambu A/S (Denmark), DizzyFix (Canada), DizzyStop (US), Dr. Reckeweg & Co. GmbH (Germany), Ocean Global (U.K.), Vertisil (US), SIDIS LABS LLC (US), and Others
Benign positional vertigo Market has been segmented on the basis of type which Benign, Paroxysmal, Positional, Vertigo, and others. On the basis of diagnosis, it is segmented into Electroencephalogram (EEG), Electronystagmography (ENG), Head CT, Head MRI, Hearing test, Magnetic resonance angiography, Caloric stimulation, and others. On the basis of treatment, the market is segmented into Canalith repositioning (sub-segmented into Semont-Toupet Maneuver, Epley Maneuver), Surgery (Posterior Canal Plugging, Laser assisted posterior canal plugging), medication (Antihistamines, Scopolamine, Sedatives), and others.
Sources: American Hearing Research Foundation, National Center for Biotechnology Information, U.S. Directorate of Industries, Annual report, White paper, Company Presentation Directorate of Industries, Annual report, White paper, Company Presentation
Regional Analysis of Benign positional vertigo Market:
Considering the global scenario of the market, due to continuous innovation and rapid adoption of new drugs and therapies, Americas is largest market for benign positional vertigo. US is holding largest market share in Americas region. European market is second largest, and especially the growth rate is higher in Western European countries. On the other hand, due increasing knowledge of disease and treatments, developing healthcare infrastructure, and increasing healthcare spending, the Asia-Pacific (APAC) is fastest growing market for benign positional vertigo and expected to grow significantly during the forecast period. Middle East and Africa (ME&A) is likely to have a limited growth in the market due to less awareness of devices and treatment.
|Market Size||Significant Value|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Type, Diagnosis and Treatment|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Ambu A/S (Denmark), DizzyFix (Canada), DizzyStop (US), Dr. Reckeweg & Co. GmbH (Germany), Ocean Global (U.K.), Vertisil (US), SIDIS LABS LLC (US)|
|Key Market Opportunities||New treatments and product development|
|Key Market Drivers||Increasing awareness of the disorder and treatment options|
Benign positional vertigo market can showcase a CAGR of 4.10% from 2022-2030.
Benign positional vertigo market is driven by the primary driver of benign positional disorder.
Lack of awareness among patients can hamper the growth of the global benign positional vertigo market.
Dr. Reckeweg & Co. GmbH, SIDIS LABS LLC, Ocean Global, DizzyFix, Ambu A/S, Vertisil, DizzyStop, and others are notable players of the global benign positional vertigo market.